TODD STRATEGY GROUP

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Oct 12, 2025

Lobbying activity 2

Health Issues

Alzheimer's Disease. Anti Obesity Medication.

Medicare/Medicaid

Medicare/Medicaid Coverage and Reimbursement. PDUFA. 340B Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.